| Response to the novel corona virus (COVID-19) pandemic across Africa: successes, challenges, and implications for the future OO Ogunleye, D Basu, D Mueller, J Sneddon, RA Seaton, ... Frontiers in pharmacology 11, 1205, 2020 | 208 | 2020 |
| The in vitro anti-plasmodial and in vivo anti-malarial efficacy of combinations of some medicinal plants used traditionally for treatment of malaria by the Meru community in Kenya JW Gathirwa, GM Rukunga, ENM Njagi, SA Omar, PG Mwitari, ... Journal of ethnopharmacology 115 (2), 223-231, 2008 | 124 | 2008 |
| Review of ongoing activities and challenges to improve the care of patients with type 2 diabetes across Africa and the implications for the future B Godman, D Basu, Y Pillay, JC Mwita, GM Rwegerera, ... Frontiers in pharmacology 11, 108, 2020 | 121 | 2020 |
| Is universal health coverage the practical expression of the right to health care? G Ooms, LA Latif, A Waris, CE Brolan, R Hammonds, EA Friedman, ... BMC International Health and Human Rights 14, 1-7, 2014 | 104 | 2014 |
| Antimalarial activity of some plants traditionally used in treatment of malaria in Kwale district of Kenya CN Muthaura, GM Rukunga, SC Chhabra, SA Omar, AN Guantai, ... Journal of ethnopharmacology 112 (3), 545-551, 2007 | 98 | 2007 |
| Establishment of a biobank and pharmacogenetics database of African populations A Matimba, MN Oluka, BU Ebeshi, J Sayi, OO Bolaji, AN Guantai, ... European Journal of Human Genetics 16 (7), 780-783, 2008 | 88 | 2008 |
| Antimalarial activity of some plants traditionally used in Meru district of Kenya CN Muthaura, GM Rukunga, SC Chhabra, SA Omar, AN Guantai, ... Phytotherapy Research: An International Journal Devoted to Pharmacological …, 2007 | 88 | 2007 |
| Fixed dose drug combinations–are they pharmacoeconomically sound? Findings and implications especially for lower-and middle-income countries B Godman, H McCabe, T D Leong, D Mueller, AP Martin, I Hoxha, ... Expert review of pharmacoeconomics & outcomes research 20 (1), 1-26, 2020 | 81 | 2020 |
| Rapid assessment of the potential paucity and price increases for suggested medicines and protection equipment for COVID-19 across developing countries with a particular focus … IA Sefah, OO Ogunleye, DO Essah, SA Opanga, N Butt, A Wamaitha, ... Frontiers in pharmacology 11, 588106, 2021 | 70 | 2021 |
| Analysis of pan-African Centres of excellence in health innovation highlights opportunities and challenges for local innovation and financing in the continent S Nwaka, A Ochem, D Besson, B Ramirez, F Fakorede, S Botros, ... BMC international health and human rights 12, 1-15, 2012 | 67 | 2012 |
| Anti-malarial activity of a polyherbal product (Nefang) during early and established Plasmodium infection in rodent models P Arrey Tarkang, FA Okalebo, LS Ayong, GA Agbor, AN Guantai Malaria journal 13, 1-11, 2014 | 66 | 2014 |
| Tackling antimicrobial resistance across sub-Saharan Africa: Current challenges and implications for the future B Godman, A Egwuenu, E Wesangula, N Schellack, AC Kalungia, ... Expert Opinion on Drug Safety 21 (8), 1089-1111, 2022 | 57 | 2022 |
| In vitro antiplasmodial activities and synergistic combinations of differential solvent extracts of the polyherbal product, Nefang P Arrey Tarkang, KD Franzoi, S Lee, E Lee, D Vivarelli, L Freitas-Junior, ... BioMed research international 2014, 2014 | 57 | 2014 |
| In vitro antiplasmodial activities and synergistic combinations of differential solvent extracts of the polyherbal product, Nefang P Arrey Tarkang, KD Franzoi, S Lee, E Lee, D Vivarelli, L Freitas-Junior, ... BioMed research international 2014, 2014 | 57 | 2014 |
| In vitro antiplasmodial activities and synergistic combinations of differential solvent extracts of the polyherbal product, Nefang P Arrey Tarkang, KD Franzoi, S Lee, E Lee, D Vivarelli, L Freitas-Junior, ... BioMed research international 2014, 2014 | 57 | 2014 |
| Challenges and innovations brought about by the COVID-19 pandemic regarding medical and pharmacy education especially in Africa and implications for the future A Etando, AA Amu, M Haque, N Schellack, A Kurdi, AA Alrasheedy, ... Healthcare 9 (12), 1722, 2021 | 53 | 2021 |
| Comparative assessment of the national pharmacovigilance systems in East Africa: Ethiopia, Kenya, Rwanda and Tanzania A Barry, S Olsson, O Minzi, E Bienvenu, E Makonnen, A Kamuhabwa, ... Drug safety 43 (4), 339-350, 2020 | 53 | 2020 |
| In vitro anti-plasmodial and in vivo anti-malarial activity of some plants traditionally used for the treatment of malaria by the Meru community in Kenya JW Gathirwa, GM Rukunga, ENM Njagi, SA Omar, AN Guantai, ... Journal of Natural Medicines 61, 261-268, 2007 | 51 | 2007 |
| Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the future B Godman, D Basu, Y Pillay, PHRF Almeida, JC Mwita, GM Rwegerera, ... Hospital practice 48 (2), 51-67, 2020 | 49 | 2020 |
| Cytochrome P450 2B6 genetic variants are associated with plasma nevirapine levels and clinical response in HIV-1 infected Kenyan women: a prospective cohort study MN Oluka, FA Okalebo, AN Guantai, RS McClelland, SM Graham AIDS research and therapy 12, 1-9, 2015 | 38 | 2015 |
